Free Trial

BioPharma Credit (LON:BPCP) Hits New 1-Year Low - What's Next?

BioPharma Credit logo with background

BioPharma Credit PLC (LON:BPCP - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 60.40 ($0.79) and last traded at GBX 60.40 ($0.79), with a volume of 111550 shares changing hands. The stock had previously closed at GBX 66.90 ($0.88).

BioPharma Credit Stock Performance

The firm has a market cap of £938.04 million, a price-to-earnings ratio of 8.98 and a beta of 0.22. The company's 50-day moving average is GBX 68.01 and its 200-day moving average is GBX 68.22.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Recommended Stories

Should You Invest $1,000 in BioPharma Credit Right Now?

Before you consider BioPharma Credit, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioPharma Credit wasn't on the list.

While BioPharma Credit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines